Accumulated IgA+ plasma cells in NASH-related fibrosis have been shown to suppress CD8+ T cells via programmed cell death ligand 1 (PD-L1) and IL-10 expression, contributing to development of HCC in NAFLD (209). The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatotic liver disease.